Call for Abstract
International Conference and Exhibition on Pharmaceutical Development and Technology, will be organized around the theme “Discover the Difference and Develop the Possibilities for Shaping Future”
PharmaTech 2017 is comprised of 14 tracks and 100 sessions designed to offer comprehensive sessions that address current issues in PharmaTech 2017.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Biopharmaceutics examines the inter relationship of the physical/chemical properties of the drug, the dosage form (drug product) in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption. It covers topics like Biopharmaceutical Technology, Therapeutic Biologics, Biologics Manufacturing, Pharmaceutical Packaging, Bioequivalence studies.
Pharmaceutics is a study concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. It covers topics like pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Also recent advances like pharmaceutical drug delivery systems, novel delivery forms, novel dosage forms, biotechnology and drug design.
- Track 1-1Physical pharmacy
- Track 1-2Pro-drug design
- Track 1-3Biologics
- Track 1-4Pharmaceutical Analysis
- Track 1-5Pharmaceutical Packaging
- Track 1-6Drug Pharmacokinetics
- Track 1-7Quality control
- Track 1-8GMP
Identifying drug targets plays essential roles in designing new drugs and combating diseases. Unfortunately, our current knowledge about drug targets is far from comprehensive. Screening drug targets in the lab is an expensive and time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop computational approaches to predict drug targets.
- Track 2-1Rational drug design
- Track 2-2Biotargets
- Track 2-3Computer Aided drug Design
- Track 2-4Bioweapons
- Track 2-5Tumour Targeting
- Track 2-6Mitochondrial Targeting
Pharmaceutical Research covers research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of recent published papers.
The recent advances in the field of Pharmaceuticals is majorly concentrated on smart drug delivery systems namely controlled drug delivery systems, gene delivery, protein delivery and vaccine delivery.
- Track 3-1Small Drug Molecules
- Track 3-2Genes
- Track 3-3Peptides
- Track 3-4Proteins
- Track 3-5Vaccines
Pharmaceutical materials are substances that are used in medical devices or in contact with biological systems. The Quality control of raw materials in pharmaceuticals has been a major setback in the pre formulation studies of API’s, hence many recent pharmaceutical research organization have taken a step to overcome these aspects by thorough quality control techniques. Biomaterials use impression from medicine, biology, chemistry, materials science and engineering. Although biomaterials are primarily used for medical applications, they are also used to multiply cells in culture, to assay for blood proteins in the clinical laboratory, in proceeding biomolecules in biotechnology, for fertility regulation implants in cattle, in diagnostic gene arrays, in the adequacy of oysters and for investigational cell-silicon "biochips." The commonality of these applications is the interaction between biological systems and simulated or modified natural materials.
- Track 4-1Biomaterials
- Track 4-2Clay materials
- Track 4-3Exfoliated vermiculite
- Track 4-4Polymers
- Track 4-5Graphene
- Track 4-6Quantum Dots
- Track 4-7Microcapsules
- Track 4-8Hybrid materials
Pharmaceutical Formulation is the process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. This process involves production of drug which characterized by two things: Stability of the product, second Acceptability to the patient. Formulation studies focuses on factors like particle size, polymorphism, pH and solubility, in order to check whether these factors will effect on bioavailability of the drug or not. Pharmaceutical Formulations include Ophthalmic Formulation, Paediatric Formulation Development, Topical Formulation and Medication Formulation.
- Track 5-1Pharmaceutical Excipients
- Track 5-2Pharmaceutical Product Development
- Track 5-3Types of Drug Formulation
- Track 5-4Pharmaceutical Research and Development
- Track 5-5Ophthalmic Formulation
- Track 5-6Paediatric Formulation Development
- Track 5-7Medication Formulation
- Track 5-8Topical Formulation Development
Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs. Pharmaceutical Biotechnology is an increasingly important area of science and technology. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes in healthcare practices and a significant contribution to the development of national economy. Biotech drug makers essentially use those microorganisms or highly complex proteins from genetically-modified living cells as components in medications to treat various diseases and conditions, from cancer to rheumatoid arthritis to multiple sclerosis. Unlike pharma companies, biotechnology focus primarily on research and development, this begins with the discovery of novel compounds, which then convoy into the clinic for further testing.
- Track 6-1Bioformulations
- Track 6-2Vaccines and Antibiotics
- Track 6-3Nucleic Acid Products
- Track 6-4Biologically inspired Pharmaceutics
- Track 6-5Microarray Technology
- Track 6-6Industrial Biotechnology
Nano pharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nano pharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the Nano scale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nano pharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via Nano pharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In today world economy, a pharmaceutical industry faces enormous pressure to deliver high-quality products to patients while maintaining profitability. Therefore pharmaceutical companies are applying nanotechnology to enhance or supplement drug target discovery, Pharmaceutical product development and drug delivery.
- Track 7-1Biomedical Nanotechnology
- Track 7-2Nanotechnology and Nanomedicine
- Track 7-3Nanotechnology Drug Delivery
- Track 7-4Nano Liposomes
- Track 7-5Nano Pharmaceuticals
- Track 7-6Medical Nanotechnology
- Track 7-7Applied Nanotechnology
Pharmaceutical technology is the appliance of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes design, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and accumulating of narcotic and other preparations used in diagnostic and determinative procedures and in the treatment of patients.
- Track 8-1Technology Transfer
- Track 8-2Pharmaceutical Technology Assessment
- Track 8-3Quality assurance and other regulatory issues
- Track 8-4Bioinformatics and Computational Biology
- Track 8-5Pharmacological Technology advances
- Track 8-6Active Pharmaceutical Ingredient (API)
- Track 8-7Pharmaceutical Packaging and labelling
- Track 8-8Advanced Bio-pharmaceutics and Pharmacokinetics
Drug manufacturing (Pharmaceutical Manufacturing) is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others. Start-up Pharmaceutical Companies, drug manufactures, contract pharmaceutical companies, pharmaceutical marketing agencies all play a major role in drug synthesis from its raw material to the final finished product.
Parenteral drug delivery is the second largest segment of this transformative pharmaceutical market eclipsed only by the more mature oral solid dosage forms accounting for nearly 30 percent of total Pharma market share. According to Survey, the market for parenteral drug delivery products is projected to rise over 10 percent annually to $86.5 billion in 2019.
- Track 9-1API synthesis
- Track 9-2Processing and Engineering
- Track 9-3Medication management
- Track 9-4Bioprocessing
- Track 9-5Molecular isotopic engineering
- Track 9-6Supply chain safety
Pharmaceutical engineering is a branch of pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the pharmaceuticals industry (i.e. drugs & biologics). While developing pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers, biomedical engineers, etc.), the specific subfield of "pharmaceutical engineering" has only emerged recently as a distinct engineering discipline. This now brings the problem-solving principles and quantitative training of engineering to complement the other scientific fields already involved in drug development.
- Track 10-1Freeze Drying techniques
- Track 10-2Pre formulation
- Track 10-3Pharmaceutical validation
- Track 10-4Pharmaceutical sales
- Track 10-5Pharmaceutical Process Equipment
- Track 10-6GMP International standards
With Drug Delivery Technology the unprecedented progresses of biomedical nanotechnology during the past few decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. To enhance their therapeutic effects and reduce the related side effects, active drug molecules should selectively accumulate in the disease area for a prolonged period with high controllability. In comparison to the conventional DDSs, the smart controlled DDSs can effectively reduce the dosage frequency, while maintaining the drug concentration in targeted organs/tissues for a longer period of time. In this sense, the controlled DDSs provide broad insights and fascinating properties for decreasing drug concentration fluctuation, reducing drug toxicities and improving therapeutic efficacy.
- Track 11-1Technology Transfer
- Track 11-2Pharmaceutical Technology Assessment
- Track 11-3Quality assurance and other regulatory issues
- Track 11-4Bioinformatics and Computational Biology
- Track 11-5Pharmacological Technology advances
- Track 11-6Active Pharmaceutical Ingredient (API)
- Track 11-7Pharmaceutical Packaging and labelling
- Track 11-8Advanced Bio-pharmaceutics and Pharmacokinetics
Instrument, apparatus, tool, software, material or other article, whether used alone or in combination used specifically for diagnostic or for therapeutic purposes and necessary for its proper application, intended for the purpose of diagnosis, prevention, monitoring, treatment or alleviation of disease are medical devices.
- Track 12-1Silver Nanoparticles
- Track 12-2Thermography and Tomography
- Track 12-3Positron-Emission Tomographic (PET) Scanning
- Track 12-4Computed Tomographic Scanning (CT Scanning)
- Track 12-5Ophthalmic and ENT Instruments
- Track 12-6Instrumentation for the Medical Use of Radioisotopes
- Track 12-7Quality by Design (QbD)
- Track 12-8Pacemakers and Defibrillators
- Track 12-9Respiratory Therapy Equipment
- Track 12-10Instrumentation for the Experimental Analysis of Behaviour
- Track 12-11Instrumentation for Psychophysiological Measurements
- Track 12-12Measurement of Blood Flow and Cardiac Output
- Track 12-13Biomedical Instrumentation Measurements
- Track 12-143D printing of medical devices
- Track 12-15Forensic Devices
- Track 12-16Elastography and Ultrasonography
Regulatory affairs (RA) also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom etc. Regulatory affairs also have a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, biologics and functional foods). Regulatory affairs is a comparatively new profession which developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. Regulatory Affairs is involved in the development of new medicinal products from early on, by integrating regulatory principles and by preparing and submitting the relevant regulatory dossiers to health authorities.
Regulatory Affairs is actively involved in every stage of development of a new medicine and in the post-marketing activities with authorized medicinal products. The Regulatory Affairs department is an important part of the organizational structure of pharmaceutical industry. Internally it liaises at the interphase of drug development, manufacturing, marketing and clinical research. Externally it is the key interface between the company and the regulatory authorities.
- Track 13-1Regulatory affairs
- Track 13-2Regulatory & Pharmacovigilance
- Track 13-3Regulatory compliance
- Track 13-4Marketing Authorizations
- Track 13-5Regulatory requirements of pharmaceutical products
- Track 13-6Clinical Affairs & Regulatory Strategies
- Track 13-7Intellectual Property Rights
- Track 13-8Medication Safety
Pharmaceutical Management is learning the business and management side of health care and the pharmaceutical industry. It provides strong focus on the basic sciences, combining biological and pharmaceutical science coursework with marketing and general management studies. Topics include pharmaceutical sales; health care and health information management; food, drug and medical device industry regulatory oversight; and pharmacy distribution systems development and implementation.
Pharmaceutical management professionals make business and financial decisions regarding research and development of new medicine, marketing, and sales. They decide which types of medication should be developed and how they will be marketed to the public once they have been approved by the Food and Drug Administration (FDA).